AzTrials
AzTrials

Gulf War SyndromeNCT00100412

Hyporeactivity and Gulf War Illness

A study testing Graded dobutamine infusions, Graded phenylephrine injections and Psychosocial challenge involving socioevaluative public speaking in people with Gulf War Syndrome and Chronic Fatigue Syndrome, run by US Department of Veterans Affairs at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research project is a follow-up to the prior VA-funded study that found that chronic fatigue reported by many Gulf War veterans may be a symptom of dysfunctional cardiovascular stress response regulation. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
Graded dobutamine infusions, Graded phenylephrine injections and Psychosocial challenge involving socioevaluative public speaking
How many people
Not given
Where
1 siteUnited States
Study dates
Oct 1999to Sep 2002
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult
  • All former military personnel who participated in the Gulf War campaign and who meet the criteria for inclusion will be eligible to participate in the study.
  • Subjects with medical conditions that could explain their symptoms or with CDC-defined psychiatric exclusions (schizophrenia, mania, bulimia, and substance abuse disorders) will not participate in the study.
  • Other exclusions will be pregnancy, traumatic brain injury, or a history of any form of cardiovascular disease or related symptoms.
  • Other restrictions on participation will include any medication that impact on cardiovascular autonomic control, benzodiazepines, and antibiotics.
  • Subjects taking nonsteroidal anti-inflammatory/analgesic agents, mild short-acting hypnotics, and SSRIs will be accepted into the study, but will be requested to withdraw from their medications with the agreement and under the supervision of their physician. These subjects will be scheduled for the study after a washout period of 5 half-lives.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Gulf War Research Center

    East Orange, New Jersey, 07018

Other trials in United States

About this study

Official title: Cardiovascular Hyporeactivity and Fatiguing Illness in Gulf War Veterans

This research project is a follow-up to the prior VA-funded study that found that chronic fatigue reported by many Gulf War veterans may be a symptom of dysfunctional cardiovascular stress response regulation. Specifically, ill veterans had diminished autonomic responses during demanding psychosocial tasks involving high level cognitive processing and emotional stress. There was a close relationship between clinical status of ill veterans and their inability to mount an appropriate physiological response under stress. The main objective of the present investigation is to determine the specific mechanism through which this abnormality may contribute to Gulf War-related chronic fatigue. We also observed that Gulf veterans with posttraumatic stress disorder (PTSD) had the most dampened autonomic activation to stressors involving higher brain activities. The second major focus of this study is to explore the role of a psychiatric disorder, specifically PTSD, as a factor in abnormalities in stress response regulation. This aspect of the study may also provide pertinent information as to the role of stress of military deployment as a contributing factor in post-Gulf War illnesses.

Read the detailed description

Objective: Our previous VA-funded study found that chronic fatigue reported by some Gulf War veterans may be a symptom of dysfunctional cardiovascular stress response regulation. Specifically, ill veterans had diminished autonomic responses during tasks involving higher brain activities, including cognitive processing and psychosocial stress. Gulf veterans with posttraumatic stress disorder (PTSD) had the most dampened autonomic activation to stressors involving higher brain activities. There was a close relationship between the clinical status of ill veterans and their inability to mount an appropriate physiological response under stress. The main objective of the present investigation is to determine the specific mechanism through which this abnormality may contribute to Gulf War-related chronic fatigue. The second major focus of this study is to explore the role of stress of military deployment as a contributing factor in post-Gulf War illnesses.

Research Plan: The research plan is to establish the mechanisms of blood pressure hyporeactivity in Gulf War veterans with chronic fatigue and PTSD. Two possibilities are being examined: one, that abnormal cardiovascular responses to stressors involve reduced responsiveness of the major cardiovascular effector systems, the peripheral arterial vasculature and the heart, to sympathetic stimulation; and two, that the locus of abnormality is in the brain, resulting in inadequate activation of the sympathetic nervous system during stressful behavioral activities. The role of wartime stress will be examined by specifically focusing on abnormalities in stress response regulation associated with Gulf War-related PTSD.

Methods: This study is being performed on four groups of Gulf War veterans, including those with symptoms that fulfill the 1994 CDC case definition for chronic fatigue syndrome (CFS), those with PTSD, those who have both CFS and PTSD, and healthy control veterans. A total of 90 veterans will be studied. The study protocol uses standard laboratory procedures to characterize abnormalities in regulation of cardiovascular function using selective pharmacological and behavioral challenges. Performance of central mechanisms of sympathetic activation during mental challenge is evaluated by measuring increases in plasma catecholamines, epinephrine and norepinephrine, during social-evaluative speech stressor. Collected plasma samples are analyzed using high performance liquid chromatography assays. The hypotheses of target organ dysfunction are evaluated using graded intravenous infusions of two drugs, phenylephrine and dobutamine, and by measuring the resultant cardiovascular responses. Phenylephrine and dobutamine are synthetic catecholamines, analogues of endogenous chemical messenger substances released by sympathetic nerve fibers and by adrenal medulla during stress response activation. Phenylephrine is an alpha-adrenergic agonist that increases blood pressure by constricting peripheral blood vessels. Dobutamine is beta-adrenergic agonist that stimulates myocardium to increase force of contraction and cardiac output. Stimulus-response curves for vasoconstrictor and inotropic adrenergic receptor mechanisms are constructed, from which measures of vasomotor and cardiac function, and autonomic reflex mechanisms are derived.

Clinical Relevance: Our research has suggested that there is a biomedical marker in Gulf veterans with illnesses characterized by severe unexplained chronic fatigue -- a diminished cardiovascular reactivity to cognitive stressors. Although this problem was served in all veterans with fatiguing illness, it was worst in the subset of those veterans who also had PTSD. Our data also suggested that the markedly diminished cardiovascular response to stress exhibited by this group may contribute to their functional impairment. The present investigation will determine (1) whether this impairment is due to PTSD, to the medical disorder of unexplained severe fatigue, or to an interaction between the two diagnoses, and (2) where in the system of blood pressure regulation lies the cause of abnormal stress responses. This work, therefore, may lead to better understanding of the causes of Gulf War Illnesses as well as ways to treat them.

Being tested
Graded dobutamine infusions, Graded phenylephrine injections, Psychosocial challenge involving socioevaluative public speaking
Medical subject headings
Persian Gulf Syndrome, Fatigue Syndrome, Chronic, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Graded dobutamine infusionsDrug

  • Graded phenylephrine injectionsDrug

  • Psychosocial challenge involving socioevaluative public speakingBehavioural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2004 (estimated)
  2. Study startOct 1999
  3. Study completionSep 2002

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
IDs, dates and publications
ClinicalTrials.gov ID
NCT00100412
Sponsor's protocol ID
MHBS-001-99S1
Status last verified
Dec 2004
First submitted
30 Dec 2004
Last updated
21 Jan 2009
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Graded dobutamine infusions, Graded phenylephrine injections and Psychosocial challenge involving socioevaluative public speaking in people with Gulf War Syndrome and Chronic Fatigue Syndrome, run by US Department of Veterans Affairs at 1 site in United States.

The full registered description is in the About this study section and the official record.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jan 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2009.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in